genprowebdirectory
GEN Edge
News
Insights
Trends for 2020
A-Lists
Topics
Bioprocessing
Cancer
Drug Discovery
OMICs
Translational Medicine
Genome Editing
Magazine
Resources
Posters
Videos
Webinars
eBooks
Podcasts
Events
New Products
Tutorial
Best of the Web
Best Apps
Subscribe
Create a Free Account
Get GEN Edge
Log In
Get GEN Magazine
Get GEN eNewsletters
Get the GEN Mobile App
Get GEN News from Alexa
Search
Advertising
Magazine Advertising
Website Banner Advertising
eNewsletter Advertising
Webinar Sponsorship
eBook Advertising
Email Nurture Campaigns
Ad Terms and Conditions
About GEN
Contact GEN
Create a Free Account
Get GEN Edge
Log In
GEN – Genetic Engineering and Biotechnology News
Mary Ann Liebert, Inc. Publishers
GEN Edge
Coronavirus
Rough Surf Ahead for California
Cancer
Alpine’s Gold Standard Approach to Drug Development
Biomarkers
Precision M&A: Invitae Eyes Growth in Personalized Cancer Tests, Services with…
Gene Therapy
Obsidian’s SWFT Response to COVID-19
Antibody Drug Conjugates
AbCellera’s CEO: Flattening the Curve of Technology Development
News
Neuroscience
Proteins Required for Brain and Heart Function Activated by Pickled Capers
Drug Discovery
Red Blood Cells Harnessed as Nanoparticle Carriers for Vaccines
Autism
Autistic Traits in Mice Associated with Blood Vessel Defects
OMICs
Single-Cell Company Berkeley Lights Sets Terms for $153M IPO
Cancer
Tumor Microenvironment Analyzed by New Nano-Radiomics Approach
Insights
All
Trends for 2020
Coronavirus
Bacteriophages Could Be a Potential Game Changer in the Trajectory of…
Bioprocessing
Digital Biomanufacturing Needs a Digital Supply Chain
Bioprocessing
Continually Collecting Virions for Manufacturing Biotech Products
Bioprocessing
AI Promises to Accelerate Process Characterization
A-Lists
July 2020 Vol. 40 No. 7
Top 10 Earners among Women Biopharma Executives
June 2020 Vol. 40 No. 6
In Praise of Lesser-Sung Life Sciences Clusters
Coronavirus
Blinking Red: 25 Missed Pandemic Warning Signs
Coronavirus
Vanquishing the Virus: 160+ COVID-19 Drug and Vaccine Candidates in Development
Coronavirus
Catching Up to Coronavirus: Top 60 Treatments in Development
Topics
All
Bioprocessing
Cancer
Drug Discovery
OMICs
Translational Medicine
Genome Editing
Drug Discovery
Red Blood Cells Harnessed as Nanoparticle Carriers for Vaccines
OMICs
Single-Cell Company Berkeley Lights Sets Terms for $153M IPO
Cancer
Tumor Microenvironment Analyzed by New Nano-Radiomics Approach
Coronavirus
Rough Surf Ahead for California
Magazine
July 2020 Vol. 40 No. 7
Rosalind Franklin the Scientist
July 2020 Vol. 40 No. 7
COVID-19 Research: Women Are Changing the Face of the Pandemic
July 2020 Vol. 40 No. 7
CRISPR Screening Explores New Dimensions
July 2020 Vol. 40 No. 7
Top 10 Earners among Women Biopharma Executives
Commentary
Clues to Healthier Aging in Cellular Senescence
Resources
All
Posters
Videos
Webinars
eBooks
Podcasts
Events
New Products
Tutorial
Best of the Web
Best Apps
Keynote Webinars
Life in the Time of Coronavirus
Upcoming Webinars
Uncover the True Identity of Your Particles with Comprehensive Particle Investigation
On Demand Webinars
GEN Live: COVID-19: Talking Next-Gen Diagnostics
Tutorial
Cultivation of Diverse and Rare Bacteria from Human Gut Microbiome
Subscribe
Create a Free Account
Get GEN Edge
Log In
Get GEN Magazine
Get GEN eNewsletters
Get the GEN Mobile App
Get GEN News from Alexa
Home
CRISPR/Cas9
CRISPR/Cas9
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
CRISPR/Cas9
Interbacterial Toxin Leads Scientists to CRISPR-Free Method for Precise Mitochondrial Gene Editing
CRISPR/Cas9
CRISPR: A New Break in the GPCR Drug Development Pipeline
CRISPR/Cas9
Alliance Task Force Joins Consensus against Germline Gene Editing
CRISPR/Cas9
Eleventh U.S. CRISPR-Cas9 Patent Awarded to University of California, U. Vienna, Charpentier
CRISPR/Cas9
Broad Institute, UC File Motions Lists in Latest CRISPR Interference Proceeding
CRISPR/Cas9
Sigma-Aldrich Petitions for Interference Between 3 Applications, UC Patents for CRISPR...
CRISPR/Cas9
Broad Institute, MilliporeSigma to Offer Non-Exclusive Licenses to CRISPR IP
CRISPR/Cas9
Mammoth Biosciences Licenses 2 UC Patents for CRISPR-Based Diagnostic Platform
CRISPR/Cas9
CRISPR and LASER ART Eliminate HIV from Mice
CRISPR/Cas9
University of California, U. Vienna, Charpentier Awarded Fourth U.S. CRISPR-Cas9 Patent
CRISPR/Cas9
MilliporeSigma to Be Awarded First U.S. CRISPR Patent
CRISPR/Cas9
Nip, Tuck, CRISPR: Gene Editing Could Give Plastic Surgery a Lift
CRISPR/Cas9
CRISPR-Cas12a More Precise Than CRISPR-Cas9
CRISPR/Cas9
DNA Crosslink Repair Central to CRISPR Insert Success
CRISPR/Cas9
Nonviral CRISPR Technology Developed for Faster, Cheaper T-Cell Engineering
Load more
Scroll Up
Please wait while you are redirected to the right page...
We use cookies to give you a better experience on genengnews.com. By continuing to use our site, you are agreeing to the use of cookies as set in our
privacy policy.
Got it!
Edit with Live CSS
/* The alert message box */ .alert { padding: 20px; background-color: #ff9800; /* Red */ color: white; margin-bottom: 15px; } /* The close button */ .closebtn { margin-left: 15px; color: white; font-weight: bold; float: right; font-size: 22px; line-height: 20px; cursor: pointer; transition: 0.3s; } /* When moving the mouse over the close button */ .closebtn:hover { color: black; } .td_module_flex_2 .entry-title { font-size: 17px; line-height: 20px; }
![This illustration shows the protein Cas12a bound to a DNA helix (red and white). [T. Yamano and H. Nishimasu discovered and published the coordinates of each atom in the protein-DNA complex. James Rybarski used those coordinates and software called PyMol to generate this illustration.]](https://www.genengnews.com/wp-content/uploads/2018/08/Aug3_2018_UnivTexas_Cas12aBoundToDNA4830232051-324x160.jpg "CRISPR-Cas12a More Precise Than CRISPR-Cas9")
![T cells engineered using nonviral CRISPR technology to express green fluorescent protein. [Alex Marson's Lab]](https://www.genengnews.com/wp-content/uploads/2018/08/Jul12_2018_AlexMarsonLab_ConfocalAlexMarsonStudy1671261882-324x160.jpg "Nonviral CRISPR Technology Developed for Faster, Cheaper T-Cell Engineering")
